Featured Research

from universities, journals, and other organizations

Protein Profile Predicts Prognosis For Lung Cancer

Date:
August 12, 2003
Source:
Vanderbilt University Medical Center
Summary:
In the future, many cancer scientists and physicians believe, a "molecular fingerprint" of an individual's cancer may be used to diagnose that patient's disease and tailor therapy.

In the future, many cancer scientists and physicians believe, a "molecular fingerprint" of an individual's cancer may be used to diagnose that patient's disease and tailor therapy.

Researchers at Vanderbilt have moved a step closer to that scenario with the identification of a distinct pattern of expression of 15 proteins in lung cancers that can predict a poor prognosis or a good prognosis. All patients in the poor prognosis group had died one year after diagnosis, while all patients in the good prognosis group were still alive. Median survival, the point at which half the patients were still alive, was six months for the poor prognosis group, compared to 33 months for the good prognosis group. "If this pattern is confirmed in larger studies, its prognostic power exceeds that of virtually any previously published standard molecular marker," the authors write in the August 9 issue of The Lancet.

The scientists also demonstrate that protein profiles obtained from a tiny amount of tumor tissue – only 1 millimeter in diameter and only 1/1000 of a millimeter in thickness -- can be used to predict risk that the cancer has spread to nearby lymph nodes.

"Involvement of lymph nodes is one of the most important factors in determining treatment strategies, so the clinical implications of these data could be significant," said Dr. David P. Carbone, Ingram Professor of Cancer Research, professor of Medicine and Cancer Biology. "Being able to use molecular markers to divide patients into high- or low-risk groups would also be very useful in determining treatment strategy."

Such a predictor could help patients and families, with their physicians, decide the most appropriate action, which could range from more aggressive therapy at the outset to avoiding therapies that are more likely to hurt quality of life for the patient than to extend that life.

The research involved investigators from the Vanderbilt-Ingram Cancer Center; Vanderbilt School of Medicine's departments of Medicine, Preventive Medicine, Molecular Physiology and Biophysics, Cardiac and Thoracic Surgery, and Pathology; and Vanderbilt's Mass Spectrometry Research Center. The project is part of Vanderbilt's Specialized Program of Research Excellence (SPORE) in lung cancer, a major initiative funded by the National Cancer Institute.

Now that the human genome has been defined, proteomics – the study of the proteins that carry out the work of the cells at the instruction of the genes – is widely considered the next frontier in biomedical research. Vanderbilt has one of the strongest programs in the world in proteomics research, with the sophisticated equipment, informatics power and statistical expertise required to comprehensively analyze the activity of thousands of proteins at once.

The investigators used mass spectrometry and customized software to analyze samples from 79 lung tumors and 14 normal lung tissue. The investigators were able, based on differences in patterns of protein expression, to distinguish with 100 percent accuracy:

* Lung tumor from normal lung;

* Primary non-small cell lung cancer (NSCLC) from normal lung;

* Primary NSCLC from cancer that had spread to the lungs from other organs; and

* Adenocarcinomas from squamous cell carcinomas, squamous cell carcinomas from large cell carcinomas.

Predictions based on protein profiles were confirmed by pathological evaluation under a microscope. In one case, a large cell carcinoma may have been misclassified based on protein patterns as an adenocarcinoma, but the investigators report that this tumor may actually be an adenocarcinoma that is too poorly differentiated to identify as such under the microscope.

The investigators note that using protein profiles to make distinctions that are already apparent under the microscope offers little use in clinical care, although the approach is potentially useful in identifying novel therapeutic targets. However, the ability to use protein profiles to predict node involvement or to identify patients as high- or low-risk could have great implications for treatment strategies, Carbone said.

"Because such small tissue samples are needed, it would be of great interest to analyze protein expression patterns of tissue samples from needle aspirations or from different cell subtypes within the lung," Carbone said. "It also would be interesting to look for patterns associated with response to specific therapies, with smoking exposure, or with preneoplasia and the progression to cancer.

"If these data are confirmed using larger numbers of patients, this technology could have significant implications for the clinical management of non-small cell lung cancer."

Co-authors were Drs. Kiyoshi Yanagisawa, Pierre Massion, John R. Roberts, Andriana Gonzales, Yu Shyr, Richard Caprioli, and Jason Moore; and Paul Larsen, Bill White and Sorena Nadaf.

In addition to funding through the NCI SPORE grant, support for the work came from other NCI grants, the Mathers Foundation and the Robert A. and Helen C. Kleberg Foundation.


Story Source:

The above story is based on materials provided by Vanderbilt University Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Vanderbilt University Medical Center. "Protein Profile Predicts Prognosis For Lung Cancer." ScienceDaily. ScienceDaily, 12 August 2003. <www.sciencedaily.com/releases/2003/08/030811071725.htm>.
Vanderbilt University Medical Center. (2003, August 12). Protein Profile Predicts Prognosis For Lung Cancer. ScienceDaily. Retrieved September 16, 2014 from www.sciencedaily.com/releases/2003/08/030811071725.htm
Vanderbilt University Medical Center. "Protein Profile Predicts Prognosis For Lung Cancer." ScienceDaily. www.sciencedaily.com/releases/2003/08/030811071725.htm (accessed September 16, 2014).

Share This



More Health & Medicine News

Tuesday, September 16, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

EU Ministers and Experts Meet to Discuss Ebola Reponse

EU Ministers and Experts Meet to Discuss Ebola Reponse

AFP (Sep. 15, 2014) — The European Commission met on Monday to coordinate aid that the EU can offer to African countries affected by the Ebola outbreak. Duration: 00:58 Video provided by AFP
Powered by NewsLook.com
Despite The Risks, Antibiotics Still Overprescribed For Kids

Despite The Risks, Antibiotics Still Overprescribed For Kids

Newsy (Sep. 15, 2014) — A new study finds children are prescribed antibiotics twice as often as is necessary. Video provided by Newsy
Powered by NewsLook.com
FDA Eyes Skin Shocks Used at Mass. School

FDA Eyes Skin Shocks Used at Mass. School

AP (Sep. 15, 2014) — The FDA is considering whether to ban devices used by the Judge Rotenberg Educational Center in Canton, Massachusetts, the only place in the country known to use electrical skin shocks as aversive conditioning for aggressive patients. (Sept. 15) Video provided by AP
Powered by NewsLook.com
Respiratory Virus Spreads To Northeast, Now In 21 States

Respiratory Virus Spreads To Northeast, Now In 21 States

Newsy (Sep. 14, 2014) — The respiratory virus Enterovirus D68, which targets children, has spread from the Midwest to 21 states. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins